Embolization of spontaneous portosystemic shunts as treatment for refractory hepatic encephalopathy
dc.contributor.author | Benitez, Carlos | |
dc.contributor.author | Munoz, Ana | |
dc.contributor.author | Poniachik, Jaime | |
dc.contributor.author | Ramirez, Felipe | |
dc.contributor.author | Munoz, Claudia | |
dc.contributor.author | Cermenati, Tomas | |
dc.contributor.author | Martinez, Nicolas | |
dc.contributor.author | Diaz, Pia | |
dc.contributor.author | Meneses, Luis | |
dc.date.accessioned | 2025-01-20T21:00:40Z | |
dc.date.available | 2025-01-20T21:00:40Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Background: Hepatic encephalopathy (HE) is a common complication of cirrhosis associated with a reduced survival. The presence of high-flux spontaneous porto-systemic shunts can induce HE even in patients with preserved liver function. Aim: To evaluate the effect of spontaneous porto-systemic shunt embolization (SPSE) over HE and its long-term evolution. Material and Methods: Retrospective analysis of 11 patients (91% males) with severe HE non-responsive to medical treatment in whom a SPSE was performed. The grade of HE (employing West Haven score), survival, MELD and Child-Pugh score, ammonia levels, degree of disability (employing the modified Rankin scale (mRs)) were evaluated before and at thirty days after procedure. Results: The most common etiology found was non-alcoholic steatohepatitis (63.6%). A reduction of at least two score points of HE was observed in all patients after thirty days. There was a significant reduction on median (IQR) West Haven score from 3 (2-3) at baseline to 1 (0-1) after the procedure (p < 0.01). Twelve months survival was 63.6%. There was a decrease in median ammonia level from 106.5 (79-165) (ug/dL) to 56 (43-61) after SPSE (p = 0.006). The median mRS score before and after the procedure was 3 (3-5) and 1 (1-2.5), respectively (p < 0.01). Conclusions: According to our experience, SPSE is a feasible and effective alternative to improve HE and functionality of patients with refractory EH. | |
dc.fuente.origen | WOS | |
dc.identifier.eissn | 0717-6163 | |
dc.identifier.issn | 0034-9887 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/92728 | |
dc.identifier.wosid | WOS:000968680000005 | |
dc.issue.numero | 7 | |
dc.language.iso | en | |
dc.pagina.final | 888 | |
dc.pagina.inicio | 879 | |
dc.revista | Revista medica de chile | |
dc.rights | acceso restringido | |
dc.subject | Embolization | |
dc.subject | Therapeutic | |
dc.subject | Fibrosis | |
dc.subject | Hepatic Encephalopathy | |
dc.subject | Liver Cirrhosis | |
dc.subject | Portosystemic Shunt | |
dc.subject | Surgical | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | Embolization of spontaneous portosystemic shunts as treatment for refractory hepatic encephalopathy | |
dc.type | artículo | |
dc.volumen | 150 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |